Skip to search formSkip to main contentSkip to account menu

1 ML Octreotide 0.1 MG/ML Injection

Known as: OCTREOTIDE ACETATE 100 ug in 1 mL SUBCUTANEOUS INJECTION, SOLUTION, OCTREOTIDE ACETATE 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION, octreotide acetate 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION [Octreotide Acetate] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
BackgroundIn single photon emission computed tomography [SPECT], high specific activity of 111In-labelled tracers will allow… 
Highly Cited
2008
Highly Cited
2008
In most types of peptide receptor radionuclide therapy, the maximum activity dose that can be administered is limited by high and… 
Highly Cited
2005
Highly Cited
2005
Purpose.To determine the optimal polyethylene glycol (PEG)-conjugate of octreotide by evaluating the effects of PEGylation… 
Highly Cited
2003
Highly Cited
2003
UNLABELLED Human somatostatin (SS) receptor (sst)-positive tumors can be visualized by gamma camera scintigraphy after the… 
Highly Cited
2002
Highly Cited
2002
Transport of a fluorescent somatostatin analogue (NBD‐octreotide) across freshly isolated functionally intact capillaries from… 
2000
2000
Transepithelial transport of a fluorescent derivative of octreotide (NBD‐octreotide) was studied in freshly isolated… 
Highly Cited
1998
Highly Cited
1998
UNLABELLED Surgery is the treatment of choice in patients with meningioma. However, the risk of postoperative, local recurrence… 
Highly Cited
1993
Highly Cited
1993
The purpose of this study was to evaluate the usefulness of a radiolabeled analog of somatostatin (iodine-123 octreotide) in the…